| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 917.90M | 1.05B | 906.80M | 797.20M | 792.30M | 624.10M |
| Gross Profit | 702.10M | 995.90M | 856.00M | 506.70M | 532.30M | 411.60M |
| EBITDA | 337.30M | 302.90M | 319.90M | 261.00M | 368.60M | 310.50M |
| Net Income | 43.40M | -57.90M | -9.50M | 100.00K | 15.40M | 79.50M |
Balance Sheet | ||||||
| Total Assets | 7.38B | 7.05B | 6.23B | 5.19B | 5.34B | 6.42B |
| Cash, Cash Equivalents and Short-Term Investments | 489.00M | 417.90M | 145.40M | 165.40M | 519.00M | 2.92B |
| Total Debt | 4.87B | 4.54B | 3.97B | 3.13B | 3.20B | 2.85B |
| Total Liabilities | 6.02B | 5.60B | 5.07B | 4.06B | 4.06B | 3.44B |
| Stockholders Equity | 1.36B | 1.45B | 1.16B | 1.12B | 1.27B | 2.98B |
Cash Flow | ||||||
| Free Cash Flow | -258.55M | -575.10M | -450.00M | -173.70M | 25.90M | 15.90M |
| Operating Cash Flow | 181.95M | 93.50M | 148.90M | 157.50M | 254.90M | 206.20M |
| Investing Cash Flow | -596.20M | -676.40M | -658.00M | -330.50M | -639.60M | 3.44B |
| Financing Cash Flow | 764.50M | 866.80M | 510.80M | -180.60M | -2.02B | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £9.30B | 8.14 | 20.43% | 4.45% | 15.76% | 254.82% | |
71 Outperform | £9.57B | 8.54 | 17.41% | 4.50% | 10.68% | 35.18% | |
69 Neutral | £2.99B | 0.40 | 3.94% | 2.78% | -19.04% | -34.52% | |
67 Neutral | £2.62B | 9.64 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.06B | 21.07 | 27.40% | 7.01% | 1.71% | -12.49% | |
59 Neutral | £9.90B | -112.68 | 1.68% | 2.86% | -4.82% | -123.58% |